Roche targets liver disease treatments with acquisition Deal includes $14.50 a share, potential milestone payments up to $6.00 a share Roche flags potential to treat obesity-related conditions The ...

FRANKFURT (Reuters) - Roche has agreed to buy U.S. biotech firm 89bio for up to $3.5 billion, joining a race to offer new liver disease treatments that complement an intense push in the area of weight ...

Co-founder and CEO of Atlassian Mike Cannon-Brookes. Source: AAP Image/Mick Tsikas Australian unicorn Atlassian has made its second major acquisition this month, handing over US$1 billion (AUD$1.5 ...

A developer looking to rehabilitate Monroe Plaza, the affordable downtown housing complex for elderly and disabled residents, has bought the property for $23.5 million. SDG Housing Partners, a ...

Companies guide developers to make the most of AI. Hammer home the changes that automation brings. Create a flywheel of change to help people learn skills. Industry experts recognize that AI is having ...

The Minnesota Attorney General’s Office is asking a judge to order a local developer to pay $4.5 million in restitution for a housing development in Lakeville that was never built. Nolosha Development ...

NFL Week 5 kicks off Thursday night, as the Rams host the 49ers. Here are the lines for every Week 5 matchup at DraftKings Sportsbook as of Oct. 4. (All times ET) 2025 NFL Week 5 Odds THURSDAY, OCT. 2 ...

Roche has dipped its toe in the M&A water with an agreement to buy US biotech 89bio and its late-stage candidate for metabolic dysfunction-associated steatohepatitis (MASH). The $14.50-per-share deal ...

When it comes to buying a water heater, we all face some common struggles. It’s never easy finding a model that’s reliable, won’t drain your savings, and can actually handle the demands of your daily ...

Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. This article dives into the happens-before ...

MapLight Therapeutics Inc. filed for an initial public offering, becoming one of few biotechnology firms to move forward with a listing in a tough year for the sector. The Redwood City, ...